14/12/2017 - 15:50

MGC to launch new cannabis skin treatment

14/12/2017 - 15:50

Bookmark

Save articles for future reference.

ASX-listed MGC Pharma is set to rollout a marijuana-derived psoriasis treatment after clinical trials in Europe showed the product, CBD Herbal Repair Cream, was effective at relieving dermatological symptoms such as irritated and inflamed skin. The first product offering from MGC’s Derma Plus line, is scheduled for launch in January and will be sold online and through existing channels.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options